LABORATORY FOR PHARMACODYNAMIC RESEARCH 

SELECTED RESEARCH PUBLICATIONS

Click on the Citation to View the Article

Aminimanizani A, Beringer PM, Kang J, Tsang L, Jelliffe RW, Shapiro BJ. Distribution and elimination of tobramycin administered in single or multiple daily doses in adult patients with cystic fibrosis. J Antimicrob Chemother 2002;50:553-59

Beringer PM, Aminimanizani A, Synold T, Scott C. Development of population pharmacokinetic models and optimal sampling times for ibuprofen tablet and suspension formulations in children with cystic fibrosis. Ther Drug Monitor 2002;24:315-21.

Montgomery MJ, Beringer PM, Aminimanizani A, Louie SG, Shapiro BJ, Jelliffe R, Gill MA. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. Antimicrob Agents Chemother 2001;45:3468-73.

Sattler FR, Qian D, Louie SG, et al. Elevated blood pressure in subjects with lipodystrophy. AIDS 2001;15:1-10.

Baydur A, Alsalek M, Louie SG, Sharma O. Respiratory muscle strength, lung function, and dyspnea in patients with sarcoidosis. CHEST 2001;120:102-8.

Aminimanizani A, Beringer PM, Jelliffe R. Comparative pharmacokinetics and pharmacodynamics of the newer fluoroquinolone agents. Clin Pharmacokinet 2001;40:169-87.

Montgomery MJ, Beringer PM, Louie SG, Gill MA. Estimation of creatinine clearance in patients with metastatic ovarian cancer. Ther Drug Monitor 2000;22:695-700.

Louie S, Chin A and Gill MA. Stability of Dalteparin in Plastic Syringes.  Am J Health-Systems Pharm. 2000;57:760-2.

Beringer PM, Vinks AA, Jelliffe RW, Shapiro BJ. Pharmacokinetics of tobramycin in adults with cystic fibrosis: implications for once-daily administration. Antimicrob Agents Chemother 2000 Apr;44(4):809-13

Lieu CLL, Chin A, and Gill MA. Five day stability of vinorelbine in 5% dextrose injection and 0.9% sodium chloride injection at room temperature.  International Journal of Pharmaceutical Compounding 1999;3:67-68.

Gill PS, Tulpule A, Espina BM, Cabriales S, Bresnahan J, Ilaw M, Louie S, Gustafson NF, Brown MA, Orcutt C, Winograd B, Scadden DT. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 1999 Jun;17(6):1876-83.

Beringer PM, Wong-Beringer A, Rho JP Predictive performance of a vancomycin-aminoglycoside population model. Ann Pharmacother 1998 Feb;32(2):176-81

Gill PS, McLaughlin T, Espina BM, Tulpule A, Louie S, Lunardi-Iskandar Y, Gallo RC. Phase I study of human chorionic gonadotropin given subcutaneously to patients with acquired immunodeficiency syndrome-related mucocutaneous Kaposi's sarcoma.J Natl Cancer Inst. 1997 Dec 3;89(23):1797-802.

Cornwell EE, Belzberg H, Berne TV, Gill MA, Theodorou D, Kern JW, Yu W, Asensio J, Demetriades D. Pharmacokinetics of aztreonam in critically ill surgical patients. Am J Health Syst Pharm. 1997 Mar 1;54(5):537-40.

 

SELECTED OTHER PUBLICATIONS

Nguyen T, Louie SG, Beringer PM, Gill MA. Potential role of macrolide antibiotics in the management of cystic fibrosis lung disease. Curr Opinion Pulm Med 2002;8:521-8.

Beringer PM. The clinical use of colistin in patients with cystic fibrosis. Curr Opinion Pulm Med 2001;7:434-40.

Beringer PM, Appleman M. Unusual respiratory bacterial flora in cystic firosis: microbiologic and clinical features. Curr Opinion Pulm Med 2000;6:545-550.

Beringer PM. New approaches to optimizing antimicrobial therapy in patients with cystic fibrosis. Curr Opinion Pulm Med 1999;5:371-77.

Moon YS, Chung KC, Gill MA. Pharmacokinetics of meropenem in animals, healthy volunteers, and patients. Clin Infect Dis 1997;24(Suppl 2):S249-55.

Louie SG, Sung J, Park S. Kaposi's sarcoma: new advances in tumor biology and pharmacotherapy. Pharmacotherapy 1997;17:1073-83.